LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Early prehabilitation in suspected locally advanced and metastatic lung cancer.

    Phillips, Iain / Petrie, Rebecca / Allan, Lindsey / Hall, Peter / Walton, Abi / McMillan, Debbie / Peacock, Catriona / Primrose, Lorraine / Vallet, Mahéva / Mencnarowksi, Julie / MacDonald, Neil / Mackean, Melanie / Barrie, Colin

    BMJ supportive & palliative care

    2024  Volume 13, Issue e3, Page(s) e908–e911

    Abstract: Objectives: The most common treatment for locally advanced and metastatic lung cancer is best supportive care. Patients with lung cancer are often comorbid with a high symptom burden. We wanted to assess whether early prehabilitation was feasible in ... ...

    Abstract Objectives: The most common treatment for locally advanced and metastatic lung cancer is best supportive care. Patients with lung cancer are often comorbid with a high symptom burden. We wanted to assess whether early prehabilitation was feasible in patients with likely lung cancer.
    Methods: Patients were offered prehabilitation if they were attending the new patient respiratory clinic, had a CT scan suggesting stage III or IV lung cancer and undergoing further investigations. Patients receiving palliative care were ineligible. All prehabilitation patients were referred to a palliative medicine physician, registered dietitian and rehabilitation physiotherapist.
    Results: 50 patients underwent prehabilitation between June 2021 and August 2022. The median age was 72 years (range 54-89 years). 48 patients had lung cancer. 84% of patients attended all three interventions.Half of the palliative care consultations focused on pain. Half of the patients seen had a change in medication. 25% of patients' weights were stable, 32% required a food-first strategy and 33% required oral nutritional supplements. 57% of patients discussed managing breathlessness with the physiotherapist.
    Conclusions: Early prehabilitation is feasible alongside the investigation of locally advanced and metastatic lung cancer. Further work will aim to assess its impact on admission to the hospital, survival and treatment rates.
    MeSH term(s) Humans ; Middle Aged ; Aged ; Aged, 80 and over ; Lung Neoplasms/complications ; Lung Neoplasms/surgery ; Preoperative Exercise ; Palliative Care ; Pain
    Language English
    Publishing date 2024-01-08
    Publishing country England
    Document type Journal Article
    ISSN 2045-4368
    ISSN (online) 2045-4368
    DOI 10.1136/spcare-2023-004349
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Early prehabilitation reduces admissions and time in hospital in patients with newly diagnosed lung cancer.

    Phillips, Iain / Deans, Maria / Walton, Abi / Vallet, Mahéva / Mencnarowksi, Julie / McMillan, Debbie / Peacock, Catriona / Hall, Peter / O'Brien, Fiona / Stares, Mark / Mackean, Melanie / Plant, Tracie / Grecian, Robert / Allan, Lindsey / Petrie, Rebecca / Blues, Duncan / Haddad, Suraiya / Barrie, Colin

    BMJ supportive & palliative care

    2024  

    Abstract: Objectives: Lung cancer is the leading cause of cancer death in the UK. Prehabilitation aims to maximise patient fitness and minimise the negative impact of anticancer treatment. What constitutes prehabilitation before non-surgical anticancer treatment ... ...

    Abstract Objectives: Lung cancer is the leading cause of cancer death in the UK. Prehabilitation aims to maximise patient fitness and minimise the negative impact of anticancer treatment. What constitutes prehabilitation before non-surgical anticancer treatment is not well established. We present data from a pilot project of Early prehabilitation In lung Cancer.
    Methods: All new patients with likely advanced lung cancer were offered prehabilitation at respiratory clinic, if fit for further investigation. Prehabilitation included assessment and appropriate intervention from a consultant in palliative medicine, registered dietitian and rehabilitation physiotherapist. Four objective endpoints were identified, namely admissions to hospital, time spent in the hospital, treatment rates and overall survival. Outcomes were to be compared with 178 prehab eligible historical controls diagnosed from 2019 to 2021.
    Results: From July 2021 to June 2023, 65 patients underwent prehabilitation and 72% of patients underwent all 3 interventions. 54 patients had a stage 3 or 4 lung cancer. In the prehab group, fewer patients attended Accident and Emergency (31.5 vs 37.4 attendances per 100 patients) and fewer were admitted (51.9 vs 67.9) when compared with historical controls. Those receiving prehab spent a lot less time in the hospital (129.7 vs 543.5 days per 100 patients) with shorter admissions (2.5 vs 8 days). Systemic anticancer treatment rates increased in the short term but were broadly similar overall. Median survival was higher in the prehabilitation group (0.73 vs 0.41 years, p=0.046).
    Conclusions: Early prehabilitation appears to reduce time spent in the hospital. It may improve survival. Further work is required to understand its full effect on treatment rates.
    Language English
    Publishing date 2024-04-17
    Publishing country England
    Document type Journal Article
    ISSN 2045-4368
    ISSN (online) 2045-4368
    DOI 10.1136/spcare-2024-004869
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Nocturnal hypoxemia in patients with cancer.

    Wilcock, Andrew / Kazi, Aqdas / Walton, Abi / Maddocks, Matthew

    Journal of pain and symptom management

    2009  Volume 38, Issue 4, Page(s) e8–10

    MeSH term(s) Humans ; Hypoxia/diagnosis ; Hypoxia/etiology ; Neoplasms/complications ; Neoplasms/diagnosis ; Oximetry ; Oxygen/analysis ; Sleep Wake Disorders/diagnosis ; Sleep Wake Disorders/etiology
    Chemical Substances Oxygen (S88TT14065)
    Language English
    Publishing date 2009-10
    Publishing country United States
    Document type Letter
    ZDB-ID 639142-4
    ISSN 1873-6513 ; 0885-3924
    ISSN (online) 1873-6513
    ISSN 0885-3924
    DOI 10.1016/j.jpainsymman.2009.05.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top